Pub Date : 2025-11-17DOI: 10.1016/j.ejpn.2025.11.003
Jenny Stritzelberger , Anna Gesmann , Daniel Delev , Stefan Schwab , Florian Putz , Markus Metzler , Regina Trollmann , Hajo Hamer
Introduction
Seizures are a common symptom of pediatric high-grade gliomas (pHGG). This study aimed to characterize these seizures in the context of the underlying tumor disease in this age group.
Methods
We retrospectively analysed the medical files of children and adolescents treated in the University Hospital Erlangen for high-grade glioma between January 2000 and May 2021 and collected data including age, sex, tumor location, histopathology, extent of initial resection, tumor recurrence, seizure characteristics, EEG findings, seizure and oncological treatment, and seizure control.
Results
Our study included 39 children (14 boys, 35.9 %) diagnosed with high-grade glioma. The median age at diagnosis was 8.5 years (range 0–17 years), and the median follow-up interval was 353 days (range 28–9146 days). 16 children had supratentorial and 23 infratentorial gliomas. 17 children (43.6 %) experienced seizures of which 10/17 (58.8 %) had supratentorial tumors. 5 of these children (20 % of all patients with epilepsy and 12.8 % of the entire cohort) presented with seizures as the first sign. 11/17 children (64.7 %) had recurrent seizures. Status epilepticus occurred in one child (2.6 %). EEG was performed in 29 patients with interictal epileptiform discharges in 4/29 (13.8 %).
Conclusions
Present data show a high incidence of seizures in pHGG associated with supratentorial but also infratentorial location. The pediatric incidence was comparable to that in adults. The majority of the children developed repetitive seizures.
{"title":"Seizures in children and adolescents with high-grade glioma: a retrospective, monocentric analysis","authors":"Jenny Stritzelberger , Anna Gesmann , Daniel Delev , Stefan Schwab , Florian Putz , Markus Metzler , Regina Trollmann , Hajo Hamer","doi":"10.1016/j.ejpn.2025.11.003","DOIUrl":"10.1016/j.ejpn.2025.11.003","url":null,"abstract":"<div><h3>Introduction</h3><div>Seizures are a common symptom of pediatric high-grade gliomas (pHGG). This study aimed to characterize these seizures in the context of the underlying tumor disease in this age group.</div></div><div><h3>Methods</h3><div>We retrospectively analysed the medical files of children and adolescents treated in the University Hospital Erlangen for high-grade glioma between January 2000 and May 2021 and collected data including age, sex, tumor location, histopathology, extent of initial resection, tumor recurrence, seizure characteristics, EEG findings, seizure and oncological treatment, and seizure control.</div></div><div><h3>Results</h3><div>Our study included 39 children (14 boys, 35.9 %) diagnosed with high-grade glioma. The median age at diagnosis was 8.5 years (range 0–17 years), and the median follow-up interval was 353 days (range 28–9146 days). 16 children had supratentorial and 23 infratentorial gliomas. 17 children (43.6 %) experienced seizures of which 10/17 (58.8 %) had supratentorial tumors. 5 of these children (20 % of all patients with epilepsy and 12.8 % of the entire cohort) presented with seizures as the first sign. 11/17 children (64.7 %) had recurrent seizures. Status epilepticus occurred in one child (2.6 %). EEG was performed in 29 patients with interictal epileptiform discharges in 4/29 (13.8 %).</div></div><div><h3>Conclusions</h3><div>Present data show a high incidence of seizures in pHGG associated with supratentorial but also infratentorial location. The pediatric incidence was comparable to that in adults. The majority of the children developed repetitive seizures.</div></div>","PeriodicalId":50481,"journal":{"name":"European Journal of Paediatric Neurology","volume":"60 ","pages":"Pages 32-35"},"PeriodicalIF":2.3,"publicationDate":"2025-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145566161","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Myotonic dystrophy type 1 (DM1) is the most common adult muscular dystrophy, with variable pediatric presentations. Data on quality of life (QoL) and fatigue in children are limited. This study evaluated clinical features, QoL, and fatigue in pediatric DM1.
Materials and methods
We conducted a cross-sectional study of 24 children with genetically confirmed DM1 followed at a tertiary pediatric neuromuscular clinic between January 2020 and January 2024. Clinical data were retrospectively reviewed, and patients were categorized into congenital, childhood-onset, or juvenile-onset subtypes. QoL and fatigue were assessed using the Pediatric Quality of Life Inventory (PedsQL) Generic Core Scales, Neuromuscular Module, and Multidimensional Fatigue Module, with both parent-proxy and self-reports obtained during routine visits.
Results
The cohort (median age 14 years, IQR:8.5–15.75) comprised congenital (n = 4), childhood-onset (n = 11), and juvenile-onset (n = 9) cases. The most common presenting symptoms were hand stiffness(75 %), weakness(54 %), and learning difficulties(50 %). Intellectual disability or learning difficulties were present in 79 %. Multisystem involvement included cardiac (25 %), respiratory (17 %), gastrointestinal (42 %), and ophthalmologic (42 %) complications. Parent-proxy reports revealed reduced QoL across all subgroups (median total scores 43.5–62.0 vs. ≥80 in healthy children). Fatigue was prominent, with sleep/rest fatigue most impaired, particularly in juvenile-onset patients (median 20.8 vs. 79.2 in childhood-onset, p = 0.007).
Discussion
Children with DM1 exhibit significant multisystem morbidity and marked impairments in QoL and fatigue. Cognitive and behavioral difficulties are prevalent, supporting the need for routine neuropsychological assessment and educational support. Multidisciplinary care should incorporate systematic QoL and fatigue evaluation, with targeted interventions such as sleep management to optimize long-term outcomes.
{"title":"Clinical features, quality of life, and fatigue in children with myotonic dystrophy type 1: A cross-sectional study","authors":"Hatice Bektaş Öntaş, Didem Ardıçlı, Nesibe Gevher Eroğlu Ertuğrul, Ayşegül Neşe Çıtak Kurt","doi":"10.1016/j.ejpn.2025.11.002","DOIUrl":"10.1016/j.ejpn.2025.11.002","url":null,"abstract":"<div><h3>Introduction/aims</h3><div>Myotonic dystrophy type 1 (DM1) is the most common adult muscular dystrophy, with variable pediatric presentations. Data on quality of life (QoL) and fatigue in children are limited. This study evaluated clinical features, QoL, and fatigue in pediatric DM1.</div></div><div><h3>Materials and methods</h3><div>We conducted a cross-sectional study of 24 children with genetically confirmed DM1 followed at a tertiary pediatric neuromuscular clinic between January 2020 and January 2024. Clinical data were retrospectively reviewed, and patients were categorized into congenital, childhood-onset, or juvenile-onset subtypes. QoL and fatigue were assessed using the Pediatric Quality of Life Inventory (PedsQL) Generic Core Scales, Neuromuscular Module, and Multidimensional Fatigue Module, with both parent-proxy and self-reports obtained during routine visits.</div></div><div><h3>Results</h3><div>The cohort (median age 14 years, IQR:8.5–15.75) comprised congenital (n = 4), childhood-onset (n = 11), and juvenile-onset (n = 9) cases. The most common presenting symptoms were hand stiffness(75 %), weakness(54 %), and learning difficulties(50 %). Intellectual disability or learning difficulties were present in 79 %. Multisystem involvement included cardiac (25 %), respiratory (17 %), gastrointestinal (42 %), and ophthalmologic (42 %) complications. Parent-proxy reports revealed reduced QoL across all subgroups (median total scores 43.5–62.0 vs. ≥80 in healthy children). Fatigue was prominent, with sleep/rest fatigue most impaired, particularly in juvenile-onset patients (median 20.8 vs. 79.2 in childhood-onset, p = 0.007).</div></div><div><h3>Discussion</h3><div>Children with DM1 exhibit significant multisystem morbidity and marked impairments in QoL and fatigue. Cognitive and behavioral difficulties are prevalent, supporting the need for routine neuropsychological assessment and educational support. Multidisciplinary care should incorporate systematic QoL and fatigue evaluation, with targeted interventions such as sleep management to optimize long-term outcomes.</div></div>","PeriodicalId":50481,"journal":{"name":"European Journal of Paediatric Neurology","volume":"60 ","pages":"Pages 24-31"},"PeriodicalIF":2.3,"publicationDate":"2025-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145529240","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-11DOI: 10.1016/j.ejpn.2025.11.001
Charly H.A. Billaud , Daniel Griffiths-King , Evangeline Wassmer , Sukhvir Wright , Elaine Foley , Amanda G. Wood
Objective
Paediatric autoimmune encephalitis and acute disseminated encephalomyelitis (ADEM) are neuroinflammatory disorders that can cause acute MRI abnormalities. Recent analyses suggest brain volume reductions months to years after disease onset. This study aimed to verify whether decreased gray matter thickness would also be observed in whole-brain cortical thickness as well as in temporal polar and orbitofrontal cortices.
Methods
A cohort of children previously diagnosed with autoimmune encephalitis (including anti-NMDA encephalitis and ADEM) were recruited at least two years after initial presentation and a cohort of typically developing children with no known neurological conditions. Cortical thickness across the whole-brain and in each region-of-interest was measured from T1w MRI scans using Freesurfer.
Results
MRI scans from 12 children with autoimmune encephalitis (mean age = 10.5; 8F:4M) and 48 controls (mean age = 10.7; 23F 25M) were analysed. The autoimmune encephalitis group had lower cortical thickness in a cluster covering the top part of the left superior occipital gyrus and the bottom part of the left superior parietal lobule (cluster size = 681.55 mm2; corrected cluster-wise p = .00459; cluster-wise Cohen's d = −8.3773). No multivariate effect on the cortical thickness of the regions-of-interest was found (Roy's Largest Root = .095, F(df) = 1.207(4); p = .319; partial η2 = .087). A small univariate effect was observed, with autoimmune encephalitis predicting lower left orbitofrontal thickness (F = 4.407, p = .040, Partial η2 = .075).
Interpretation
Children with autoimmune encephalitis may be subject to local cortical thinning in the long term.
{"title":"MRI cortical thickness in paediatric auto-immune encephalitis and acute disseminated encephalomyelitis","authors":"Charly H.A. Billaud , Daniel Griffiths-King , Evangeline Wassmer , Sukhvir Wright , Elaine Foley , Amanda G. Wood","doi":"10.1016/j.ejpn.2025.11.001","DOIUrl":"10.1016/j.ejpn.2025.11.001","url":null,"abstract":"<div><h3>Objective</h3><div>Paediatric autoimmune encephalitis and acute disseminated encephalomyelitis (ADEM) are neuroinflammatory disorders that can cause acute MRI abnormalities. Recent analyses suggest brain volume reductions months to years after disease onset. This study aimed to verify whether decreased gray matter thickness would also be observed in whole-brain cortical thickness as well as in temporal polar and orbitofrontal cortices.</div></div><div><h3>Methods</h3><div>A cohort of children previously diagnosed with autoimmune encephalitis (including anti-NMDA encephalitis and ADEM) were recruited at least two years after initial presentation and a cohort of typically developing children with no known neurological conditions. Cortical thickness across the whole-brain and in each region-of-interest was measured from T1w MRI scans using Freesurfer.</div></div><div><h3>Results</h3><div>MRI scans from 12 children with autoimmune encephalitis (mean age = 10.5; 8F:4M) and 48 controls (mean age = 10.7; 23F 25M) were analysed. The autoimmune encephalitis group had lower cortical thickness in a cluster covering the top part of the left superior occipital gyrus and the bottom part of the left superior parietal lobule (cluster size = 681.55 mm<sup>2</sup>; corrected cluster-wise p = .00459; cluster-wise Cohen's d = −8.3773). No multivariate effect on the cortical thickness of the regions-of-interest was found (Roy's Largest Root = .095, F(df) = 1.207(4); p = .319; partial η<sup>2</sup> = .087). A small univariate effect was observed, with autoimmune encephalitis predicting lower left orbitofrontal thickness (<em>F</em> = 4.407, <em>p</em> = .040, Partial <em>η</em><sup><em>2</em></sup> = .075).</div></div><div><h3>Interpretation</h3><div>Children with autoimmune encephalitis may be subject to local cortical thinning in the long term.</div></div>","PeriodicalId":50481,"journal":{"name":"European Journal of Paediatric Neurology","volume":"60 ","pages":"Pages 36-43"},"PeriodicalIF":2.3,"publicationDate":"2025-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145566126","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-01DOI: 10.1016/j.ejpn.2025.10.014
Daniel Griffiths-King , Evangeline Wassmer , Sukhvir K. Wright
{"title":"Observational evidence of the treatment efficacy of IVIG as maintenance therapy for pediatric MOGAD","authors":"Daniel Griffiths-King , Evangeline Wassmer , Sukhvir K. Wright","doi":"10.1016/j.ejpn.2025.10.014","DOIUrl":"10.1016/j.ejpn.2025.10.014","url":null,"abstract":"","PeriodicalId":50481,"journal":{"name":"European Journal of Paediatric Neurology","volume":"59 ","pages":"Page A3"},"PeriodicalIF":2.3,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145446426","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Fatigue, depression, and decreased health-related quality of life (HRQoL) are commonly reported among patients with pediatric-onset multiple sclerosis (POMS). However, their interplay and distinct manifestations remain insufficiently understood.
Objective
This study aimed to assess fatigue, depressive symptoms, and HRQoL in a well-characterized cohort of POMS patients in comparison to age- and sex-matched healthy controls (HCs).
Methods
Participants completed the Fatigue Severity Scale (FSS), the 36-Item Short Form Survey (SF-36), and the Revised Children's Anxiety and Depression Scale (RCADS). Comparative analyses between groups were conducted using standard parametric and non-parametric statistical tests.
Results
A total of 41 patients with POMS (mean age: 17.98 ± 1.94 years; 75.6 % female) and 35 healthy controls (mean age: 17.43 ± 1.17 years; 60 % female) were enrolled. Fatigue was significantly more prevalent and severe in the POMS group, as evidenced by higher FSS scores (p = 0.006) and increased fatigue rates (22 % vs. 2.8 %, p = 0.026). No significant between-group differences were found in depression or anxiety scores (p > 0.05). In the SF-36, POMS patients exhibited significantly lower vitality (p = 0.009) and general health scores (p = 0.001), whereas other domains remained comparable.
Conclusion
Fatigue and reduced perceptions of vitality and general health are prominent concerns in POMS, even in the absence of overt depressive or anxiety symptoms. These findings underscore the need for early integration of psychological assessments and fatigue-specific interventions within multidisciplinary care to enhance long-term quality of life.
{"title":"Fatigue, depression, and health-related quality of life in pediatric-onset multiple sclerosis: A comparative study from a tertiary care center","authors":"Nazlı Balcan Karaca , Salih Akbaş , Müge Kuzu Kumcu , Ercan Demir , Kıvılcım Gücüyener","doi":"10.1016/j.ejpn.2025.10.012","DOIUrl":"10.1016/j.ejpn.2025.10.012","url":null,"abstract":"<div><h3>Background</h3><div>Fatigue, depression, and decreased health-related quality of life (HRQoL) are commonly reported among patients with pediatric-onset multiple sclerosis (POMS). However, their interplay and distinct manifestations remain insufficiently understood.</div></div><div><h3>Objective</h3><div>This study aimed to assess fatigue, depressive symptoms, and HRQoL in a well-characterized cohort of POMS patients in comparison to age- and sex-matched healthy controls (HCs).</div></div><div><h3>Methods</h3><div>Participants completed the Fatigue Severity Scale (FSS), the 36-Item Short Form Survey (SF-36), and the Revised Children's Anxiety and Depression Scale (RCADS). Comparative analyses between groups were conducted using standard parametric and non-parametric statistical tests.</div></div><div><h3>Results</h3><div>A total of 41 patients with POMS (mean age: 17.98 ± 1.94 years; 75.6 % female) and 35 healthy controls (mean age: 17.43 ± 1.17 years; 60 % female) were enrolled. Fatigue was significantly more prevalent and severe in the POMS group, as evidenced by higher FSS scores (p = 0.006) and increased fatigue rates (22 % vs. 2.8 %, p = 0.026). No significant between-group differences were found in depression or anxiety scores (p > 0.05). In the SF-36, POMS patients exhibited significantly lower vitality (p = 0.009) and general health scores (p = 0.001), whereas other domains remained comparable.</div></div><div><h3>Conclusion</h3><div>Fatigue and reduced perceptions of vitality and general health are prominent concerns in POMS, even in the absence of overt depressive or anxiety symptoms. These findings underscore the need for early integration of psychological assessments and fatigue-specific interventions within multidisciplinary care to enhance long-term quality of life.</div></div>","PeriodicalId":50481,"journal":{"name":"European Journal of Paediatric Neurology","volume":"59 ","pages":"Pages 114-118"},"PeriodicalIF":2.3,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145394879","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-01DOI: 10.1016/j.ejpn.2025.10.006
Suzanne M. Nevin , Fleur A. Le Marne , Lauren Kelada , Claire E. Wakefield , Erin Beavis , Rebecca Macintosh , Elizabeth E. Palmer , Rachel McLoughlin
Aim
Patients with Severe Neurological Impairment (SNI) have progressive conditions of the central nervous system, resulting in permanent cognitive and motor disabilities and enduring hypercomplexity. This study aimed to explore clinicians’ shared psychosocial experience of caring for families of children with SNI, including the challenges, and components of care that bring clinicians meaning and purpose, to identify resource pathways to sustain clinicians.
Method
We purposively recruited multidisciplinary clinicians with expertise caring for patients with SNI to participate in a series of four sequential and semi-structured reflective practice workshops. We recorded workshops and performed a qualitative content analysis, following verbatim transcription.
Results
We conducted sixteen workshops with multidisciplinary clinicians including paediatricians (n = 14), paediatric neurologists (n = 5), allied health professionals (n = 3), clinical geneticists (n = 2), clinical nurse specialists (n = 2), a paediatric nephrologist (n = 1), a neurosurgeon (n = 1) and a metabolic specialist (n = 1). Workshops focused on three primary domains: ‘the struggle’, ‘making a difference’ and ‘finding purpose and meaning’. Clinicians acknowledged psychosocial challenges and the limits to their medical expertise, emphasising the importance of ongoing reflective practice and proactive multidisciplinary collaboration to sustain themselves and empower patients. In the final workshop series, clinicians identified their preferences for multipronged, multimodal resources, centred on connection, reflection, and support.
Conclusion
This research provides in-depth insight into how multidisciplinary clinicians caring for patients with SNI cope with challenges and gain meaning and purpose in their role.
Co-designed clinician interventions, coupled with integrated and structured reflective practice will address identified challenges and foster clinician meaning and purpose, in supporting their patients.
{"title":"Connect, pause and reflect: Multidisciplinary clinicians’ shared challenges and sustaining strategies caring for children with Severe Neurological Impairment","authors":"Suzanne M. Nevin , Fleur A. Le Marne , Lauren Kelada , Claire E. Wakefield , Erin Beavis , Rebecca Macintosh , Elizabeth E. Palmer , Rachel McLoughlin","doi":"10.1016/j.ejpn.2025.10.006","DOIUrl":"10.1016/j.ejpn.2025.10.006","url":null,"abstract":"<div><h3>Aim</h3><div>Patients with Severe Neurological Impairment (SNI) have progressive conditions of the central nervous system, resulting in permanent cognitive and motor disabilities and enduring hypercomplexity. This study aimed to explore clinicians’ shared psychosocial experience of caring for families of children with SNI, including the challenges, and components of care that bring clinicians meaning and purpose, to identify resource pathways to sustain clinicians.</div></div><div><h3>Method</h3><div>We purposively recruited multidisciplinary clinicians with expertise caring for patients with SNI to participate in a series of four sequential and semi-structured reflective practice workshops. We recorded workshops and performed a qualitative content analysis, following verbatim transcription.</div></div><div><h3>Results</h3><div>We conducted sixteen workshops with multidisciplinary clinicians including paediatricians (n = 14), paediatric neurologists (n = 5), allied health professionals (n = 3), clinical geneticists (n = 2), clinical nurse specialists (n = 2), a paediatric nephrologist (n = 1), a neurosurgeon (n = 1) and a metabolic specialist (n = 1). Workshops focused on three primary domains: ‘the struggle’, ‘making a difference’ and ‘finding purpose and meaning’. Clinicians acknowledged psychosocial challenges and the limits to their medical expertise, emphasising the importance of ongoing reflective practice and proactive multidisciplinary collaboration to sustain themselves and empower patients. In the final workshop series, clinicians identified their preferences for multipronged, multimodal resources, centred on connection, reflection, and support.</div></div><div><h3>Conclusion</h3><div>This research provides in-depth insight into how multidisciplinary clinicians caring for patients with SNI cope with challenges and gain meaning and purpose in their role.</div><div>Co-designed clinician interventions, coupled with integrated and structured reflective practice will address identified challenges and foster clinician meaning and purpose, in supporting their patients.</div></div>","PeriodicalId":50481,"journal":{"name":"European Journal of Paediatric Neurology","volume":"60 ","pages":"Pages 15-23"},"PeriodicalIF":2.3,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145514771","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-01DOI: 10.1016/j.ejpn.2025.10.011
Stéphane Auvin
{"title":"From controlled trials to real-world evidence: Learning from the glycopyrronium treatment journey","authors":"Stéphane Auvin","doi":"10.1016/j.ejpn.2025.10.011","DOIUrl":"10.1016/j.ejpn.2025.10.011","url":null,"abstract":"","PeriodicalId":50481,"journal":{"name":"European Journal of Paediatric Neurology","volume":"59 ","pages":"Page A2"},"PeriodicalIF":2.3,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145423427","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-01DOI: 10.1016/j.ejpn.2025.04.011
Adrián García Ron , Eva Arias Vivas , Guillermo Fernando Ruiz Ocaña de las Cuevas , Elsa Santana Cabrera , Rafael Sánchez-del Hoyo , Marta Bote Gascón
{"title":"Corrigendum to “Utility of greater occipital nerve anesthetic blockade in the treatment of status migrainosus in the pediatric emergency department” [Europ. J. Paediatr. Neurol. 55 (2025) 65-69]","authors":"Adrián García Ron , Eva Arias Vivas , Guillermo Fernando Ruiz Ocaña de las Cuevas , Elsa Santana Cabrera , Rafael Sánchez-del Hoyo , Marta Bote Gascón","doi":"10.1016/j.ejpn.2025.04.011","DOIUrl":"10.1016/j.ejpn.2025.04.011","url":null,"abstract":"","PeriodicalId":50481,"journal":{"name":"European Journal of Paediatric Neurology","volume":"59 ","pages":"Page 120"},"PeriodicalIF":2.3,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144769238","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
扫码关注我们
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号